Prostate, Renal, Bladder and Testicular Cancers Team

At UNM Cancer Center, our Prostate, Renal, Bladder and Testicular Cancers Team offers the latest, most advanced treatments. These include second generation dendritic vaccines for kidney cancer and heat shock protein inhibition in prostate and bladder cancers. Prostate cancers, especially, can vary in how aggressive they can be.

The order in which you get your care can make a great difference in your cancer outcome, so our team works closely to create the best plan for you. Our team also conducts groundbreaking research to learn better ways to treat these cancers.

“The idea is to stimulate an immune response to the cancer. By using the body’s immune response to viruses, we incidentally create an immune response to the cancer.”

— Thomas Schroeder, MD
On a phase 3 clinical trial that tests a combination of immune therapy plus radiation therapy for prostate cancer.

2,290
estimated new cases of kidney and renal pelvis, prostate, testicular and urinary bladder cancers in New Mexico for 2021
Source: American Cancer Society